X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12866) 12866
Book Review (2097) 2097
Publication (1624) 1624
Conference Proceeding (601) 601
Book Chapter (120) 120
Dissertation (70) 70
Book / eBook (2) 2
Data Set (2) 2
Government Document (1) 1
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9744) 9744
animals (7624) 7624
cardiac-hypertrophy (7512) 7512
cardiac hypertrophy (5022) 5022
male (4331) 4331
humans (4170) 4170
rats (3995) 3995
cardiac & cardiovascular systems (3990) 3990
mice (2672) 2672
heart (2538) 2538
peripheral vascular disease (2524) 2524
heart-failure (2101) 2101
heart failure (2068) 2068
hypertrophy (2026) 2026
cell biology (1982) 1982
hypertension (1848) 1848
myocardium - metabolism (1756) 1756
female (1746) 1746
physiology (1636) 1636
biochemistry & molecular biology (1564) 1564
expression (1556) 1556
pharmacology & pharmacy (1485) 1485
gene-expression (1391) 1391
signal transduction (1357) 1357
gene expression (1336) 1336
myocardium - pathology (1334) 1334
disease models, animal (1281) 1281
myocytes, cardiac - metabolism (1259) 1259
rats, sprague-dawley (1236) 1236
cardiomegaly - metabolism (1182) 1182
oxidative stress (1146) 1146
cells, cultured (1138) 1138
apoptosis (1058) 1058
fibrosis (1023) 1023
activation (1008) 1008
pressure-overload (998) 998
proteins (981) 981
rodents (974) 974
cardiomegaly - pathology (967) 967
rats, wistar (954) 954
cardiomyocytes (934) 934
article (933) 933
physiological aspects (912) 912
left-ventricular hypertrophy (910) 910
medicine, research & experimental (902) 902
myocardial-infarction (865) 865
echocardiography (864) 864
cardiomyopathy (856) 856
mice, inbred c57bl (853) 853
induced cardiac-hypertrophy (852) 852
phosphorylation (848) 848
blood pressure (838) 838
myocytes, cardiac - pathology (835) 835
heart enlargement (828) 828
research (828) 828
middle aged (821) 821
blood-pressure (815) 815
cardiomegaly - physiopathology (813) 813
hematology (779) 779
angiotensin-ii (777) 777
in-vivo (749) 749
analysis (747) 747
cardiovascular system (734) 734
myocytes, cardiac - drug effects (731) 731
heart diseases (718) 718
adult (714) 714
cardiology (699) 699
hypertension - physiopathology (697) 697
mice, knockout (686) 686
gene expression regulation (672) 672
disease (669) 669
inhibition (645) 645
abridged index medicus (630) 630
cells (622) 622
blood pressure - drug effects (613) 613
angiotensin ii (612) 612
myocytes (612) 612
cardiovascular (607) 607
failure (592) 592
time factors (588) 588
cardiomegaly - genetics (578) 578
myocardium (567) 567
health aspects (564) 564
mice, transgenic (561) 561
dilated cardiomyopathy (559) 559
angiotensin (553) 553
growth (552) 552
hypertrophy, left ventricular - physiopathology (547) 547
aged (542) 542
calcium (541) 541
risk factors (538) 538
heart failure - physiopathology (535) 535
dysfunction (534) 534
rats, inbred shr (532) 532
calcium - metabolism (521) 521
kinases (515) 515
cardiovascular disease (508) 508
rna, messenger - metabolism (502) 502
cardiomegaly - etiology (501) 501
microrna (491) 491
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13081) 13081
Chinese (65) 65
Japanese (65) 65
French (49) 49
German (47) 47
Spanish (33) 33
Russian (31) 31
Portuguese (28) 28
Korean (14) 14
Polish (5) 5
Italian (3) 3
Persian (3) 3
Czech (2) 2
Lithuanian (2) 2
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Life Sciences, ISSN 0024-3205, 09/2019, Volume 232, pp. 116635 - 116635
The pathological cardiac hypertrophy will develop into heart failure, which has no effective treatment currently. Previous studies have proved that microRNAs... 
Cardiac hypertrophy | MicroRNA-92b-3p | Cardiomyocyte | HAND2
Journal Article
Life Sciences, ISSN 0024-3205, 09/2019, Volume 233
Resveratrol is a polyphenolic compound that has received much attention for its use in ameliorating various systemic pathological conditions. The present study... 
Resveratrol | Cardiac hypertrophy | mTOR | Chronic intermittent hypoxia
Journal Article
International Heart Journal, ISSN 1349-2365, 2017
The mechanism of cardiac hypertrophy involving microRNAs (miRNAs) is attracting increasing attention. Our study aimed to investigate the role of miR-10a in... 
Cardiomyocyte | Cardiac hypertrophy
Journal Article
ACTA PHYSIOLOGICA, ISSN 1748-1708, 04/2016, Volume 216, Issue 4, pp. 383 - 385
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 09/2019, Volume 141, pp. 291 - 298
Increased levels of reactive isolevuglandins (IsoLGs) are associated with vascular inflammation and hypertension, two important factors affect heart failure... 
Heart failure | Cardiac hypertrophy | Inflammation | Lung | Fibrosis | Index Medicus
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 08/2011, Volume 301, Issue 2, pp. R491 - R499
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 10/2012, Volume 303, Issue 8, pp. H979 - H988
Journal Article
Journal of Physiology, ISSN 0022-3751, 2019
During compensated hypertrophy in vivo fractional shortening (FS) remains constant until heart failure (HF) develops, when FS decreases from 70% to 39%.... 
heart failure | sodium | calcium | Na | ATPase | K | cardiac hypertrophy
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2006, Volume 147, Issue 6, pp. 587 - 595
Journal Article
Circulation research, 01/2019, Volume 124, Issue 1, pp. 9 - 11
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 02/2013, Volume 304, Issue 3, pp. H427 - H435
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 12/2018, Volume 125, pp. 106 - 116
High-fat diet (HFD) induces cardiac hypertrophy; however, the underlying cellular and molecular mechanisms are yet unclear. In the present study, we... 
Cardiac hypertrophy | 11β-HSD1 | Palmitic acid | Mineralocorticoid receptor | Glucocorticoid receptor
Journal Article
Circulation Journal, ISSN 1346-9843, 2017
Background:Pressure overload induces cardiac hypertrophy, which often ends in heart failure. Afadin is an adaptor protein that is ubiquitously expressed and,... 
Heart failure | Mechanical stress | Angiotensin | Cardiac hypertrophy
Journal Article
Cardiovascular Research, ISSN 0008-6363, 08/2004, Volume 63, Issue 3, pp. 423 - 432
The renin-angiotensin system (RAS) and transforming growth factor-β (TGF-β ) play a pivotal role in the development of cardiac hypertrophy and heart failure.... 
Heart failure | Smads | Angiotensin | Cross-talk | Cardiac hypertrophy | TGF-β | β-Adrenoceptors
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 05/2019, Volume 20, Issue 9, p. 2178
Modelling is essential for a better understanding of microcirculatory pathophysiology. In this study we tested our hyperoxia-mouse model with healthy and... 
Cardiac hypertrophy | Wavelet transform | Diabetes | Mouse | Hyperoxia | LDF | mouse | hyperoxia | cardiac hypertrophy | diabetes | wavelet transform
Journal Article
The Journal of Physiology, ISSN 0022-3751, 03/2015, Volume 593, Issue 6, pp. 1385 - 1386
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.